News

Research carried out in collaboration between MINT and University College London has won a prestigious award from the Journal of Cardiovascular Engineering Technologies (CVET).

"The 'Sphere': A Dedicated Bifurcation Aneurysm Flow-Diverter Device" was the most downloaded article published in CVET in 2015-16, demonstrating the widespread interest in the pioneering technology developed by MINT. The paper presents results from Computational Fluid Dynamics (CFD) modelling of ‘Sphere’, which...

MINT and Lumendi have been incredibly successful thus far in their collaboration on the Endolumenal Surgical Platform (ESP). ESP is a disposable device that fits over an endoscope to provide improved visualization inside the colon. The Lumendi team recently hired 4 new team members for Marketing, Regulatory Affairs and Quality Assurance, Research and Development, and Medical Affairs. The company plans to file the ESP device with the FDA in late 2016, and hopes to have FDA approval in the...

The MINT program is growing and recently appointed Andrew Harvey and Russell Corwin as Biomedical Engineers.

Harvey and Corwin will work across the full spectrum of MINT projects. 

Prior to joining MINT, Harvey worked as a Biomedical Design Engineer for Nuvasive, Inc in San Diego, California where he developed spinal procedures, focusing on minimally invasive procedures, specifically the Transforaminal Lumbar Interbody Fusion (TLIF) and extreme Lateral Interbody Fusion (XLIF)....

The MINT program has appointed Matthew Baird Director of Operations and Strategy. Baird joins us from the Center for Advanced Digestive Care (CADC) at NewYork-Presbyterian Hospital (NYP) where he had responsibilities for matters relating to strategy, operations and financial management.

Prior to joining NYP in 2012, Baird worked in a range of healthcare roles in the United Kingdom, including strategic planning at Guy's and St Thomas' NHS Foundation Trust, financial management at NHS...

A new patent for our Endolumenal Surgical Platform (ESP) technology has issued today by The United States Patent and Trademark Office (USPTO).

ESP is a medical device developed by MINT that works in conjunction with current endoscopes to significantly enhance endoscopy and polypectomy, enabling endolumenal treatment of challenging polyps that were formerly referred to surgery. We estimate that in the US alone some 40,000 open surgeries for the removal of difficult polyps could be...

We are excited to announce that a new patent for our Spherical Aneurysm Device technology for the treatment of cerebral aneurysms has issued in the United States.

The MINT team is developing a set of next-generation flow diverting devices to treat complex cerebral aneurysms located at vessel bifurcations.  The spherical shape of the devices enable clinicians to endovascularly treat a wide range of aneurysms, including aneurysms with challenging geometries or locations within the...

We are excited to announce the encouraging results from our flow-diverter device ‘Sphere’, intended to treat cerebral bifurcation aneurysms, have been published!

The paper is published in the latest issue of Cardiovascular Engineering and Technology (CVET), titled  “The ‘Sphere’: A Dedicated Bifurcation Aneurysm Flow-Diverter Device”, and show that the device offers very significant levels of flow reduction in a number of anatomically accurate aneurysm sizes and locations, with many...

A second patent for our Sphere technology has issued today by The United States Patent and Trademark Office (USPTO).

Our disruptive Sphere technology is designed specifically for endovascular treatment of cerebral aneurysms occurring at bifurcations – a condition for which before the development of Sphere there was no acceptable endovascular treatment. The device is spherical in shape and consists of a high density patterned surface constructed from Nitinol® wire which when placed,...